allergy banner

Videos


Articles


Citations: 3117

Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)

Bousquet, J., Khaltaev, N., Cruz, A.A., Denburg, J., Fokkens, W.J., Togias, A. et al. Allergy. 2008; 63: 8-160

Citations: 2226

The global burden of asthma: executive summary of the GINA Dissemination Committee Report

Masoli, M., Fabian, D., Holt, S., Beasley, R. Allergy. 2004; 59: 469-478

Citations: 1258

A revised nomenclature for allergy - An EAACI position statement from the EAACI nomenclature task force

Johansson, S.G.O., Hourihane, J., Bousquet, J., Bruijnzeel-Koomen, C., Dreborg, S., Haahtela, T. et al. Allergy. 2001; 56: 813-824

Citations: 868

Position Paper - Allergen Standardization and Skin-Tests

Dreborg, S. and Frew, A. Allergy. 1993; 48: 49-54

Citations: 724

Allergenic pollen and pollen allergy in Europe

D’Amato, G., Cecchi, L., Bonini, S., Nunes, C., Annesi-Maesano, I., Behrendt, H. et al. Allergy. 2007; 62: 976-990

Citations: 723

Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE

Humbert, M., Beasley, R., Ayres, J., Slavin, R., Hébert, J., Bousquet, J. et al. Allergy. 2005; 60: 309-316

Citations: 709

The EAACI/GA(2)LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update

Zuberbier, T., Aberer, W., Asero, R., Bindslev-Jensen, C., Brzoza, Z., Canonica, G., W., et al. Allergy. 2014; 69: 868– 887

Citations: 634

Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study

Jacobsen, L., Niggemann, B., Dreborg, S., Ferdousi, H.A., Halken, .S., Høst, A. et al. Allergy. 2007; 62: 943-948

Citations: 540

Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis

Wilson, D., R., Torres Lima, M. and Durham, S. R. Allergy. 2005; 60: 4-12
Citations: 1003

Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China

Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741

Citations: 138

Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19

Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581

Citations: 124

COVID-19 in a designated infectious diseases hospital outside Hubei Province, China

Cai, Q., Huang, D., Ou, P., Yu, H., Zhu, Z., Xia, Z. et al. Allergy. 2020; 75: 1742– 1752

Citations: 91

Eleven faces of coronavirus disease 2019

Dong, X., Cao, Y.-Y., Lu, X.-X., Zhang, Du, H., J.-J., Yan, Y.-Q. et al. Allergy. 2020; 75: 1699– 1709

Citations: 69

Distinct characteristics of COVID-19 patients with initial rRT-PCR-positive and rRT-PCR-negative results for SARS-CoV-2

Zhang, J.-j., Cao, Y.-y., Dong, X., Wang, B.-c., Liao, M.-y., Lin, J. et al. Allergy. 2020; 75: 1809-1812

Citations: 61

Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors

Radzikowska, U., Ding, M., Tan, G., Zhakparov, D., Peng, Y., Wawrzyniak, P. et al. Allergy. 2020; 75: 2828– 2844

Citations: 41

Is BCG vaccination affecting the spread and severity of COVID-19?

Ozdemir, C., Kucuksezer, U.,C. and Tamay, Z.,U. Allergy. 2020; 75: 1824-1827

Citations: 40

Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic?

Gursel, M. and Gursel, I. Allergy. 2020; 75: 1815-1819

Citations: 38

Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement

Bousquet, J., Akdis, C.,A., Jutel, M., Bachert, C., Klimek, L., Agache, I. et al. Allergy. 2020; 75: 2440-2444

Citations: 21

The need for clean air: The way air pollution and climate change affect allergic rhinitis and asthma

Eguiluz-Gracia, I., Mathioudakis, A.,G., Bartel, S., Vijverbeg, S., J., H., Fuertes, E. et al. Allergy. 2020; 75: 2170– 2184

The Maternal Diet Index in Pregnancy is associated with offspring allergic diseases: The Healthy Start Study

Venter, C., Palumbo, M.P., Glueck, D.H., Sauder, K.A., O’Mahony, L., Fleischer, D.M. et al. Allergy. 2021; first published: 21 May 2021

Invited review: The role of allergen-specific IgE, IgG and IgA in allergic disease

Shamji, M.H., Valenta, R., Jardetzky, T., Verhasselt, V., Durham, S.R., Wurtzen, P.A. and van Neerven, R.J. Allergy. 2021; first published: 17 May 2021

Eosinophils and activation markers after allergen challenge - a pilot study for three dimensional analysis in the bronchial mucosa

Prenzler, F., Tschernig, T., Sewald, K., Veres, T.Z., Rittinghausen, S., Krug, N., Hohlfeld, J.M. and Braun, A. Allergy. 2021; first published: 17 May 2021

Dupilumab efficacy in chronic rhinosinusitis with nasal polyps from SINUS-52 is unaffected by eosinophilic status

Fujieda, S., Matsune, S., Takeno, S., Ohta, N., Asako, M., Bachert, C., et al. Allergy. 2021; first published: 16 May 2021

Accurate and Reproducible Diagnosis of Peanut Allergy Using Epitope Mapping

Suárez-Fariñas, M., Suprun, M., Kearney, P., Getts, R., Grishina, G., Hayward, C., et al. Allergy. 2021; first published: 15 May 2021

Acute scrotum in a 8-year-old Italian child caused by extraintestinal anisakiasis in a seaside area

Centonze, A., Capillo, S., Mazzei, A., Salerno, D., Sinopoli, D., Prosperi Porta, I. and Baldassarre, E. Allergy. 2021; 76: 1601-1602

ACE2 downregulation in olfactory mucosa: eosinophilic rhinosinusitis as COVID-19 protective factor?

Marin, C., Tubita, V., Langdon, C., Fuentes, M., Rojas-Lechuga, M.J., Valero, A., et al. Allergy. 2021; first published: 13 May 2021

Epigenetic regulation of epithelial dectin-1 through an IL-33-STAT3 axis in allergic disease

Yong, H.M., Gour, N., Sharma, D., Khalil, S.M., Lane, A.P. and Lajoie, S. Allergy. 2021; first published: 13 May 2021

An injectable excipient prevents anti-polyethylene glycol antibody mediated hypersensitivity

Liu, Y., Smith, C.A., Payton, M., Jenkins, D., Janke, L.J. and Relling, M.V. Allergy. 2021;

Innovative robust basophil activation test using a novel gating strategy reliably diagnosing allergy with full automation

Behrends, J., Schwager, C., Hein, M., Scholzen, T., Kull, S. and Jappe, U. Allergy. First published: 11 May 2021

Prof. Mario Sánchez Borges: An enduring legacy and a life well-lived

Pawankar, R., Rosenwasser, L.J. and Canonica, G.W. Allergy. First published: 10 May 2021

Distinction between peanut allergy and tolerance by characterization of B-cell receptor repertoires

Ehlers, A.M., den Hartog Jager, C.F., Knulst, A.C. and Otten, H.G. Allergy. First published: 10 May 2021

Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19

Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581

Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China

Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741

Unexplained recurrent fever: when is autoinflammation the explanation?

Kallinich, T., Gattorno, M., Grattan, C.,E., de Koning, H.,D., Traidl-Hoffmann, C., Feist, E., et al. Allergy. 2013; 68: 285– 296

The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria

Zuberbier, T., Aberer, W., Asero, R., Abdul Latiff, A., H., Baker, D., Ballmer-Weber, B. et al. Allergy. 2018; 73: 1393- 1414

A compendium answering 150 questions on COVID-19 and SARS-CoV-2

Riggioni, C., Comberiati, P., Giovannini, M., Agache, I., Akdis, M., Alves-Correia, M. et al. Allergy. 2020; 75: 2503– 2541

Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19

Bousquet, J., Anto, J.M., Czarlewski, W., Haahtela, T. Fonseca, S.,C., Iaccarino, G. et al. Allergy. 2021; 76: 735– 750

Eleven faces of coronavirus disease 2019

Dong, X., Cao, Y.-Y., Lu, X.-X., Zhang, Du, H., J.-J., Yan, Y.-Q. et al. Allergy. 2020; 75: 1699– 1709

Thirty-six COVID-19 cases preventively vaccinated with mumps-measles-rubella vaccine: All mild course

Larenas-Linnemann, D.,E. and Rodríguez-Monroy, F. Allergy. 2021; 76: 910-914

Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)

Bousquet, J., Khaltaev, N., Cruz, A.A., Denburg, J., Fokkens, W.J., Togias, A. et al. Allergy. 2008; 63: 8-160

Asthma and COVID-19: Is asthma a risk factor for severe outcomes?

Johnston, S.,L. Allergy. 2020; 75: 1543-1545

Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China

Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741

COVID-19 in a designated infectious diseases hospital outside Hubei Province, China

Cai, Q., Huang, D., Ou, P., Yu, H., Zhu, Z., Xia, Z. et al. Allergy. 2020; 75: 1742– 1752

Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19

Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581

Distinct characteristics of COVID-19 patients with initial rRT-PCR-positive and rRT-PCR-negative results for SARS-CoV-2

Zhang, J.-j., Cao, Y.-y., Dong, X., Wang, B.-c., Liao, M.-y., Lin, J. et al. Allergy. 2020; 75: 1809-1812

Eleven faces of coronavirus disease 2019

Dong, X., Cao, Y.-Y., Lu, X.-X., Zhang, Du, H., J.-J., Yan, Y.-Q. et al. Allergy. 2020; 75: 1699– 1709

Is BCG vaccination affecting the spread and severity of COVID-19?

Ozdemir, C., Kucuksezer, U.,C. and Tamay, Z.,U. Allergy. 2020; 75: 1824-1827

Basophil activation test: A diagnostic, predictive and monitoring assay for allergen immunotherapy

Alpan, O., Layhadi, J.A., Ulrik Sønder, S., Li, H. and Shamji, M.H. Allergy. 2021; 76: 1321-1324

The axis of the receptor for advanced glycation endproducts in asthma and allergic airway disease

Perkins, T.,N, Donnell, M.,L, Oury, T.,D. Allergy. 2021; 76: 1350– 1366

The global burden of illness of peanut allergy: A comprehensive literature review

Lieberman, J.,A, Gupta, R., Knibb, R.,C., Haselkorn, T., Tilles, S., Mack, D., P. and Poussel, G. et al. Allergy. 2021; 76: 1367– 1384

Butyrate as a bioactive human milk protective component against food allergy

Paparo, L, Nocerino, R, Ciaglia, E, et al. Allergy. 2021; 76: 1398– 1415

Predicting food allergy: The value of patient history reinforced

Lyons, SA, Knulst, AC, Burney, PGJ, et al. Allergy. 2021; 76: 1454– 1462

Identification of Pru du 6 as a potential marker allergen for almond allergy

Kabasser, S, Hafner, C, Chinthrajah, S, et al. Allergy. 2021; 76: 1463– 1472

Peanut-induced anaphylaxis in children and adolescents: Data from the European Anaphylaxis Registry

Maris, I., Dölle-Bierke, S., Renaudin, J.-M., Lange, L., Koehli, A., Spindler, T. et al. Allergy. 2021; 76: 1517-1527

Pollen induces reactivation of latent herpesvirus and differentially affects infected and uninfected murine macrophages

Speidel, J.D., Gilles, S., Steer, B., Vafadari, B., Rauer, D., Traidl-Hoffmann, C. and Adler, H. Allergy. 2021; 76: 1539-1542

PIPE-cloned human IgE and IgG4 antibodies: New tools for investigating cow's milk allergy and tolerance

Pranger, C.L., Fazekas-Singer, J., Köhler, V.K., Pali-Schöll, I., Fiocchi, A., Karagiannis, S.N. et al. Allergy. 2021; 76: 1553-1556

Assessing the protective role of allergic disease in gastrointestinal tract cancers using Mendelian randomization analysis

Yuan, S., Vithayathil, M., Kar, S., Carter, P., Mason, A.M., Xie, S.-H., Burgess, S. and Larsson, S.C. Allergy. 2021; 76: 1559-1562

Trained immunity and allergy: State of the art and future perspectives

Wang, H., Song, J., Pan, L., Deng, Y.-K., Yao, Y., Wang, Z.-C. et al. Allergy. 2021; 76: 1565-1568

Elucidating the α-Gal syndrome at the molecular allergen level

Kiewiet, M.B.G., Grundström, J., Apostolovic, D., Andersson, M., Borres, M.P., Hamsten, C. et al. Allergy. 2021; 76: 1576-1578

The roadmap for allergology in Europe: The European training requirements for the specialty of allergology

Gerth van Wijk, R., Mülleneisen, N., Demoly, P., Olaguibel, J.M., Popov, T.A., Schmid-Grendelmeier, P. and Tsilochristou, O. Allergy. 2021; 76: 1588-1591

Junior Members Corner



ALLERGY COLLEGE 2021 - a JMA initiative to approach allergy and immunology to undergraduate students.


The Allergy College is an important initiative for increasing the visibility of our specialty among the future generation of scientists and clinicians across Europe. This year, a renewed virtual edition will take place during the 2021 EAACI Annual Hybrid Congress. The Allergy College is an excellent opportunity for undergraduate science and medical students to learn the challenges and rewards of starting a professional career in the field of Allergy and Immunology.

To apply, please send your CV and a short motivation letter. The selected students will receive waived digital registration for the Hybrid EAACI 2021 Congress. In addition, they will be matched with a mentor to prepare an abstract regarding a clinical case, a proposal for a scientific review or a short research study for presentation at the virtual Allergy College session.


Deadlines:



  • May 10: application deadline

  • May 20: matching with mentor

  • June 20: abstract submission deadline (250 words)

  • June 25: acceptance notification

We encourage you to promote this initiative amongst your medical and basic science undergraduate students and professional/academic network. If you are interested in collaborating as a mentor, please contact us for further information at the email address juniormembers@eaaci.org.



EAACI JM board representatives met with allergy fellows training in Turkey


The EAACI JM board in collaboration with the Turkish National Society of Allergy and Clinical Immunology (TNSACI) held a virtual meeting on April 18, 2021 for the allergy fellows training in Turkey. The aim of the meeting was to share knowledge and experiences about the educational and scientific opportunities offered by EAACI.

The meeting was hosted by Dr. Aslı Gelincik (foreign relations chair of the TNSACI Executive Committee (ExCom) and an EAACI member-at-large in the ExCom), and Dr. Stefano del Giacco (EAACI Education & Specialty VP). The EAACI JM board was represented by the JM board chair, Dr. Carmen Riggioni, and the secretary, Dr. Pasquale Comberiati.

The meeting topics were chosen based on a 22-question survey prepared by Drs Aslı Gelincik and Özge Aktaş Öztürk (TNSACI- EAACI National Societies Committee (NAS) JM representative). The survey was completed by the fellows in training and evaluated knowledge and expectations about JM activities and educational programmes. In this regard, Dr. Stefano del Giacco explained the structuring of EAACI and the novel and comprehensive “EAACI e-learning platform” which provides user-friendly resources including courses, webcasts, podcasts, lectures, and more.

Dr. Carmen Riggioni described the EAACI activities targeted to JMs such as the clinical and research Fellowship Programs, the Mentorship Program, scholarships for the EAACI congresses and meetings, the JM e-bulletin, the JM corners at Allergy and PAI journals’ websites and, in particular, the new collaboration between JMs and the EAACI journals that attracted considerable attention by the audience.

The meeting was attended by more than 300 young allergists in Turkey and gave more visibility to EAACI educational and scientific activities. Attendees felt the spirit of being part of the EAACI family in a friendly atmosphere. The EAACI JM board aims to organize additional meetings with JMs throughout Europe to motivate young allergists to engage with EAACI, which will contribute to their academic and scientific development.

Looking forward to meeting you all at the 2021 EAACI Annual Hybrid Congress!
Best regards,
The JMA


Social Media